Balfaxar
Prothrombin Complex Concentrate (Human)
Listed by Octapharma USA Inc
- Strength
- 25.5 [iU]/mL, 16.5 [iU]/mL, 24 [iU]/mL, 22 [i…
- Form
- Powder, For Solution
- Route
- Intravenous
- Class
- Anti-coagulant; Blood Coagulation Factor; Hum…
What it contains
- Coagulation Factor Ix Human 25.5 [iU]/mL
- Prothrombin 16.5 [iU]/mL
- Coagulation Factor Vii Human 24 [iU]/mL
- Coagulation Factor X Human 22 [iU]/mL
- Protein C 22 [iU]/mL
- Protein S Human 26 [iU]/mL
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
FDA record
| Dosage form | Powder, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Anti-coagulant; Blood Coagulation Factor; Human Blood Coagulation Factor; Human Blood Coagulation Factor; Human Blood Coagulation Factor |
| Approval route | BLA — biologic licence |
| NDC code | 68982-261 |
| FDA application | BLA125776 |
| Package sizes listed | 2 |
| Marketed since | November 2023 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.